abstract |
The present invention relates to a compound of formula (0):n□ wherein Q, A1-A8, R4 and R5 and each have the meaning as described herein. The compounds of formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and conditions in which undesired or over-activated NF-kB signaling is observed. |